Ourotech Competitors and Similar CompaniesClear all
Ourotech's competitors and similar companies include Olema Oncology, Aeglea and Rain Therapeutics.
 Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  Aeglea Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics. |  Rain Therapeutics Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients. | ||
Founding Date | Founding Date 2015 | Founding Date 2007 | Founding Date 2013 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Waterloo, CA HQ | Locations San Francisco, US HQ San Francisco, US | Locations Austin, US HQ | Locations Newark, US HQ |
Employees | Employees 3 | Employees 9630% increase | Employees 65117% increase | Employees 6343% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 679.2 m | Valuation ($) 48.6 m | Valuation ($) 44 m |
Financial | ||||
Net income | Net income N/A | Net income ($162.5m) (FY, 2025) | Net income ($155.2m) (FY, 2025) | Net income ($75.7m) (FY, 2022) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 145.1m | Total funding raised N/A | Total funding raised $ 82.4m |
For sources of this data, please see the company profile
View Company Profiles
Olema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyAeglea
HQ
Austin, US
Employees
65
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
View companyRain Therapeutics
HQ
Newark, US
Employees
63↑ 43% increase
Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients.
View company